Skip to main content

Advertisement

SpringerLink
Log in

Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects

  • Original Paper
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

Abstract

To evaluate whether the extracellular volume fraction (ECV) measured using cardiac magnetic resonance (CMR) imaging can detect myocardial tissue changes in dilated cardiomyopathy (DCM) without late gadolinium enhancement (LGE). Forty-one DCM patients and 10 healthy volunteers underwent pre- and post-T1 mapping using a modified Look-Locker Inversion recovery sequence, LGE, and cine MRI on a 3-T CMR system. LGE-MR findings were used to divide DCM patients into two groups: Group A had no apparent LGE, and Group B had LGE apparent in at least one segment. The ECV of the left ventricle (LV) myocardium (16 segments) was calculated in the short-axis view as follows: ECV = [(ΔR1 of myocardium/ΔR1 of LV blood pool)] × (1 − hematocrit), where R1 = 1/T1, ΔR1 = post-contrast R1 − pre-contrast R1. The LV ejection fraction (LVEF) was obtained from cine MRI images. The mean myocardial ECV in LGE (−) segments in Group A + B was compared to that of controls. The mean myocardial ECV in Group A was compared to that of LGE (−) segments in Group B. The correlation between LV systolic function and the mean myocardial ECV of the whole myocardium was evaluated in all groups. Among the 41 DCM patients, 22 were in Group A, and 19 were in Group B. The mean ECV of DCM patents (n = 41, 568 segments, 30.7 % ± 5.9) was significantly higher (P < 0.001) than that of the control group (n = 10, 157 segments, 25.6 % ± 3.2). The ECV was inversely related to LVEF in Group A (r = −0.551, P = 0.008), Group B (r = −0.525, P = 0.021), and Group A + B (r = −0.550, P < 0.001). The ECV measured by MRI could be a useful parameter in evaluating diffuse myocardial changes in DCM patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

CMR:

Cardiac magnetic resonance

DCM:

Dilated cardiomyopathy

ECV:

Extracellular volume fraction

LGE:

Late gadolinium enhancement

LV:

Left ventricle

LVEDD:

Left-ventricular end-diastolic diameter

LVEF:

Left-ventricular ejection fraction

MOLLI:

Modified Look-Locker Inversion recovery

PSIR:

Phase-sensitive inversion recovery

RV:

Right ventricle

References

  1. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ (2008) Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 52(19):1574–1580

    Article  PubMed  Google Scholar 

  2. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB, American Heart A, Council on Clinical Cardiology HF, Transplantation C, Quality of C, Outcomes R, Functional G, Translational Biology Interdisciplinary Working G, Council on E, Prevention (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113(14):1807–1816

  3. Harris SR, Glockner J, Misselt AJ, Syed IS, Araoz PA (2008) Cardiac MR imaging of nonischemic cardiomyopathies. Magn Reson Imaging Clin N Am 16(2):165–183

    Article  PubMed  Google Scholar 

  4. O’Donnell DH, Abbara S, Chaithiraphan V, Yared K, Killeen RP, Martos R, Keane D, Cury RC, Dodd JD (2012) Cardiac MR imaging of nonischemic cardiomyopathies: imaging protocols and spectra of appearances. Radiology 262(2):403–422

    Article  PubMed  Google Scholar 

  5. Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA (2011) Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 57(8):891–903

    Article  PubMed  Google Scholar 

  6. Maisch B (1996) Ventricular remodeling. Cardiology 87(Suppl 1):2–10

    Article  PubMed  Google Scholar 

  7. Sun Y, Weber KT (1998) Cardiac remodelling by fibrous tissue: role of local factors and circulating hormones. Ann Med 30(Suppl 1):3–8

    CAS  PubMed  Google Scholar 

  8. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, Pennell DJ (2003) Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108(1):54–59

    Article  CAS  PubMed  Google Scholar 

  9. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M, Sheppard MN, Poole-Wilson PA, Pennell DJ (2006) Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48(10):1977–1985

    Article  PubMed  Google Scholar 

  10. Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S, Morarji K, Brown TD, Ismail NA, Dweck MR, Di Pietro E, Roughton M, Wage R, Daryani Y, O’Hanlon R, Sheppard MN, Alpendurada F, Lyon AR, Cook SA, Cowie MR, Assomull RG, Pennell DJ, Prasad SK (2013) Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 309(9):896–908

    Article  CAS  PubMed  Google Scholar 

  11. Deckers JW, Hare JM, Baughman KL (1992) Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy: a seven-year survey of 546 consecutive diagnostic procedures in a tertiary referral center. J Am Coll Cardiol 19(1):43–47

    Article  CAS  PubMed  Google Scholar 

  12. From AM, Maleszewski JJ, Rihal CS (2011) Current status of endomyocardial biopsy. Mayo Clin Proc 86(11):1095–1102

    Article  PubMed Central  PubMed  Google Scholar 

  13. Ugander M, Oki AJ, Hsu LY, Kellman P, Greiser A, Aletras AH, Sibley CT, Chen MY, Bandettini WP, Arai AE (2012) Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J 33(10):1268–1278

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Kellman P, Wilson JR, Xue H, Bandettini WP, Shanbhag SM, Druey KM, Ugander M, Arai AE (2012) Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience. J Cardiovasc Magn Reson 14:64

    Article  PubMed Central  PubMed  Google Scholar 

  15. Sado DM, Flett AS, Banypersad SM, White SK, Maestrini V, Quarta G, Lachmann RH, Murphy E, Mehta A, Hughes DA, McKenna WJ, Taylor AM, Hausenloy DJ, Hawkins PN, Elliott PM, Moon JC (2012) Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart 98(19):1436–1441

    Article  PubMed  Google Scholar 

  16. Lalande A, Salve N, Comte A, Jaulent MC, Legrand L, Walker PM, Cottin Y, Wolf JE, Brunotte F (2004) Left ventricular ejection fraction calculation from automatically selected and processed diastolic and systolic frames in short-axis cine-MRI. J Cardiovasc Magn Reson 6(4):817–827

    Article  PubMed  Google Scholar 

  17. Baldy C, Douek P, Croisille P, Magnin IE, Revel D, Amiel M (1994) Automated myocardial edge detection from breath-hold cine-MR images: evaluation of left ventricular volumes and mass. Magn Reson Imaging 12(4):589–598

    Article  CAS  PubMed  Google Scholar 

  18. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS, American Heart Association Writing Group on Myocardial S, Registration for Cardiac I (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105(4):539–542

    Article  PubMed  Google Scholar 

  19. Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, Gatehouse PD, Arai AE, Friedrich MG, Neubauer S, Schulz-Menger J, Schelbert EB, Society for Cardiovascular Magnetic Resonance I, Cardiovascular Magnetic Resonance Working Group of the European Society of C (2013) Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 15:92

    Article  Google Scholar 

  20. Piechnik SK, Ferreira VM, Lewandowski AJ, Ntusi NA, Banerjee R, Holloway C, Hofman MB, Sado DM, Maestrini V, White SK, Lazdam M, Karamitsos T, Moon JC, Neubauer S, Leeson P, Robson MD (2013) Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI. J Cardiovasc Magn Reson 15:13

    Article  PubMed Central  PubMed  Google Scholar 

  21. Wu KC, Weiss RG, Thiemann DR, Kitagawa K, Schmidt A, Dalal D, Lai S, Bluemke DA, Gerstenblith G, Marban E, Tomaselli GF, Lima JA (2008) Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 51(25):2414–2421

    Article  PubMed Central  PubMed  Google Scholar 

  22. Mongeon FP, Jerosch-Herold M, Coelho-Filho OR, Blankstein R, Falk RH, Kwong RY (2012) Quantification of extracellular matrix expansion by CMR in infiltrative heart disease. JACC Cardiovasc Imaging 5(9):897–907

    Article  PubMed Central  PubMed  Google Scholar 

  23. Green JJ, Berger JS, Kramer CM, Salerno M (2012) Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 5(4):370–377

    Article  PubMed  Google Scholar 

  24. Lee JJ, Liu S, Nacif MS, Ugander M, Han J, Kawel N, Sibley CT, Kellman P, Arai AE, Bluemke DA (2011) Myocardial T1 and extracellular volume fraction mapping at 3 tesla. J Cardiovasc Magn Reson 13:75

    Article  PubMed Central  PubMed  Google Scholar 

  25. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, McGregor C, Moon JC (2010) Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 122(2):138–144

    Article  PubMed  Google Scholar 

  26. Klein C, Nekolla SG, Balbach T, Schnackenburg B, Nagel E, Fleck E, Schwaiger M (2004) The influence of myocardial blood flow and volume of distribution on late Gd-DTPA kinetics in ischemic heart failure. J Magn Reson Imaging 20(4):588–593

    Article  PubMed  Google Scholar 

  27. Miller CA, Naish JH, Bishop P, Coutts G, Clark D, Zhao S, Ray SG, Yonan N, Williams SG, Flett AS, Moon JC, Greiser A, Parker GJ, Schmitt M (2013) Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging 6(3):373–383

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by a faculty research grant of Yonsei University College of Medicine for 2011 (6-2011-0190).

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Radiology, Research Institute of Radiological Science, Severance Hospital, Yonsei University Medical Center, Seoul, South Korea

    Yoo Jin Hong, Young Jin Kim, Jin Hur, Hye-Jeong Lee, Sae Rom Hong, Young Joo Suh & Byoung Wook Choi

  2. Department of Radiology, Research Institute of Radiological Science, Gangnam Severance Hospital, Yonsei University Medical Center, 211 Eonjuro, Gangnam-Gu, Seoul, 135-720, Korea

    Chul Hwan Park & Tae Hoon Kim

  3. Siemens AG Healthcare Sector, Erlangen, Germany

    Andreas Greiser

  4. Siemens Healthcare, Seoul, Republic of Korea

    Mun Young Paek

Authors
  1. Yoo Jin Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chul Hwan Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Young Jin Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jin Hur
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hye-Jeong Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sae Rom Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Young Joo Suh
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Andreas Greiser
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Mun Young Paek
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Byoung Wook Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Tae Hoon Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tae Hoon Kim.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hong, Y.J., Park, C.H., Kim, Y.J. et al. Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects. Int J Cardiovasc Imaging 31 (Suppl 1), 115–122 (2015). https://doi.org/10.1007/s10554-015-0595-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-015-0595-0

Keywords

Search

Navigation